ReP USP - Resultado da busca

Artigo de periodico
Experimental inoculation of aggregatibacter actinomycetemcomitans and streptococcus gordonii and its impact on alveolar bone loss and oral and gut microbiomes (2024)
Rocha, Catarina Medeiros ; Kawamoto, Dione ; Martins, Fernando Henrique ; Bueno, Manuela Rocha ; Ishikawa, Karin Hitomi ; Ando-Suguimoto, Ellen Sayuri ; Carlucci, Aline Ramos ; Arroteia, Leticia Sandoli ; Casarin, Renato V. ; Saraiva, Luciana ; Simionato, Maria Regina Lorenzetti ; Mayer, Marcia Pinto Alves
Source: International Journal of Molecular Sciences. Unidades: FO, ICB
Subjects: MICROBIOLOGIA, ALVEOLOPLASTIA, ACTINOBACILLUS ACTINOMYCETEMCOMITANS, STREPTOCOCCUS, PERIODONTITE, OSSO E OSSOS, ALVEOLECTOMIA, BIOFILMES, GENGIVA, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, INTESTINO DE ANIMAL, ODONTOPATIA, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Catarina Medeiros et al. Experimental inoculation of aggregatibacter actinomycetemcomitans and streptococcus gordonii and its impact on alveolar bone loss and oral and gut microbiomes. International Journal of Molecular Sciences, v. 25, n. 15, p. 19 , 2024Tradução . . Disponível em: https://doi.org/10.3390/ijms25158090Dopi. Acesso em: 16 nov. 2024.
APA
Rocha, C. M., Kawamoto, D., Martins, F. H., Bueno, M. R., Ishikawa, K. H., Ando-Suguimoto, E. S., et al. (2024). Experimental inoculation of aggregatibacter actinomycetemcomitans and streptococcus gordonii and its impact on alveolar bone loss and oral and gut microbiomes. International Journal of Molecular Sciences, 25( 15), 19 . doi:10.3390/ijms25158090Dopi
NLM
Rocha CM, Kawamoto D, Martins FH, Bueno MR, Ishikawa KH, Ando-Suguimoto ES, Carlucci AR, Arroteia LS, Casarin RV, Saraiva L, Simionato MRL, Mayer MPA. Experimental inoculation of aggregatibacter actinomycetemcomitans and streptococcus gordonii and its impact on alveolar bone loss and oral and gut microbiomes [Internet]. International Journal of Molecular Sciences. 2024 ; 25( 15): 19 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/ijms25158090Dopi
Vancouver
Rocha CM, Kawamoto D, Martins FH, Bueno MR, Ishikawa KH, Ando-Suguimoto ES, Carlucci AR, Arroteia LS, Casarin RV, Saraiva L, Simionato MRL, Mayer MPA. Experimental inoculation of aggregatibacter actinomycetemcomitans and streptococcus gordonii and its impact on alveolar bone loss and oral and gut microbiomes [Internet]. International Journal of Molecular Sciences. 2024 ; 25( 15): 19 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/ijms25158090Dopi
Artigo de periodico
Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 (2024)
Santos, Yasmin Silva ; Gamon, Thaís Helena Martins ; Azevedo, Marcela Santiago Pacheco de ; Bielavsky, Mônica ; Darido, Maria Laura Goussain ; Oliveira, Danielle Bruna Leal de ; Souza, Edmarcia Elisa de ; Luvizotto, Maria Cecília Rui ; Ackerman, Hans Christian; Carvalho, Leonardo José de Moura ; Epiphanio, Sabrina ; Wrenger, Carsten ; Durigon, Edison Luiz ; Marinho, Claudio Romero Farias
Source: Frontiers in Pharmacology. Unidades: FCF, ICB, BIOTECNOLOGIA
Subjects: PARASITOLOGIA, MICROBIOLOGIA, COVID-19, INIBIDORES DE ENZIMAS, DOENÇAS RESPIRATÓRIAS, ANGIOTENSINA II, SISTEMA RENINA-ANGIOTENSINA, ANTIVIRAIS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin Silva et al. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19. Frontiers in Pharmacology, v. 15, 2024Tradução . . Disponível em: https://doi.org/10.3389/fphar.2024.1414406. Acesso em: 16 nov. 2024.
APA
Santos, Y. S., Gamon, T. H. M., Azevedo, M. S. P. de, Bielavsky, M., Darido, M. L. G., Oliveira, D. B. L. de, et al. (2024). Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19. Frontiers in Pharmacology, 15. doi:10.3389/fphar.2024.1414406
NLM
Santos YS, Gamon THM, Azevedo MSP de, Bielavsky M, Darido MLG, Oliveira DBL de, Souza EE de, Luvizotto MCR, Ackerman HC, Carvalho LJ de M, Epiphanio S, Wrenger C, Durigon EL, Marinho CRF. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fphar.2024.1414406
Vancouver
Santos YS, Gamon THM, Azevedo MSP de, Bielavsky M, Darido MLG, Oliveira DBL de, Souza EE de, Luvizotto MCR, Ackerman HC, Carvalho LJ de M, Epiphanio S, Wrenger C, Durigon EL, Marinho CRF. Lisinopril increases lung ACE2 levels and SARS-CoV-2 viral load and decreases inflammation but not disease severity in experimental COVID-19 [Internet]. Frontiers in Pharmacology. 2024 ; 15[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fphar.2024.1414406
Artigo de periodico
Saps1–3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice (2024)
Barbosa, Pedro F.; Gonçalves, Diego S.; Ramos, Lívia de Souza ; Mello, Thaís P.; Braga-Silva, Lys A.; Pinto, Marcia R.; Branquinha, Marta H. ; Santos, André L. S. ; Taborda, Carlos Pelleschi
Source: Infectious Disease Reports. Unidade: ICB
Subjects: MICROBIOLOGIA, CITOMETRIA DE FLUXO, CAMUNDONGOS, INTERAÇÃO CELULAR, ENZIMAS HIDROLÍTICAS, CANDIDA ALBICANS, FUNGOS MITOSPORICOS, IMUNOGLOBULINAS, NITROGÊNIO, ANTÍGENOS DE FUNGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Pedro F. et al. Saps1–3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice. Infectious Disease Reports, v. 16, n. 4, p. 572-586, 2024Tradução . . Disponível em: https://doi.org/10.3390/idr16040043. Acesso em: 16 nov. 2024.
APA
Barbosa, P. F., Gonçalves, D. S., Ramos, L. de S., Mello, T. P., Braga-Silva, L. A., Pinto, M. R., et al. (2024). Saps1–3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice. Infectious Disease Reports, 16( 4), 572-586. doi:https://doi.org/10.3390/idr16040043
NLM
Barbosa PF, Gonçalves DS, Ramos L de S, Mello TP, Braga-Silva LA, Pinto MR, Branquinha MH, Santos ALS, Taborda CP. Saps1–3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice [Internet]. Infectious Disease Reports. 2024 ; 16( 4): 572-586.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/idr16040043
Vancouver
Barbosa PF, Gonçalves DS, Ramos L de S, Mello TP, Braga-Silva LA, Pinto MR, Branquinha MH, Santos ALS, Taborda CP. Saps1–3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice [Internet]. Infectious Disease Reports. 2024 ; 16( 4): 572-586.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/idr16040043
Artigo de periodico
Zika virus infection impairs synaptogenesis, induces neuroinflammation, and could be an environmental risk factor for autism spectrum disorder outcome (2024)
Ohki, Cristine Marie Yde ; Benazzato, Cecília ; Linden, Vanessa van der
Source: Biochimica et Biophysica Acta. Molecular Basis of Disease. Unidade: ICB
Subjects: MICROBIOLOGIA, ZIKA VÍRUS, INFECÇÕES POR VÍRUS DE RNA, ASTRÓCITOS, TRANSTORNO DO ESPECTRO AUTISTA, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS, ESTUDOS DE COORTES, CRIANÇAS, APOPTOSE, GLUTAMATOS, MICROCEFALIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OHKI, Cristine Marie Yde e BENAZZATO, Cecília e LINDEN, Vanessa van der. Zika virus infection impairs synaptogenesis, induces neuroinflammation, and could be an environmental risk factor for autism spectrum disorder outcome. Biochimica et Biophysica Acta. Molecular Basis of Disease, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.bbadis.2024.167097. Acesso em: 16 nov. 2024.
APA
Ohki, C. M. Y., Benazzato, C., & Linden, V. van der. (2024). Zika virus infection impairs synaptogenesis, induces neuroinflammation, and could be an environmental risk factor for autism spectrum disorder outcome. Biochimica et Biophysica Acta. Molecular Basis of Disease. doi:10.1016/j.bbadis.2024.167097
NLM
Ohki CMY, Benazzato C, Linden V van der. Zika virus infection impairs synaptogenesis, induces neuroinflammation, and could be an environmental risk factor for autism spectrum disorder outcome [Internet]. Biochimica et Biophysica Acta. Molecular Basis of Disease. 2024 ;[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.bbadis.2024.167097
Vancouver
Ohki CMY, Benazzato C, Linden V van der. Zika virus infection impairs synaptogenesis, induces neuroinflammation, and could be an environmental risk factor for autism spectrum disorder outcome [Internet]. Biochimica et Biophysica Acta. Molecular Basis of Disease. 2024 ;[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.bbadis.2024.167097
Artigo de periodico
Oral administration of Lactobacillus acidophilus LA5 prevents alveolar bone loss and alters oral and gut microbiomes in a murine periodontitis experimental model (2024)
Cataruci, Amália Cristina de Souza; Kawamoto, Dione ; Shimabukuro, Natali ; Ishikawa, Karin Hitomi ; Ando-Suguimoto, Ellen Sayuri ; Ribeiro, Rodolfo Alvarenga ; Nicastro, Gianlucca Gonçalves ; Albuquerque-Souza, Emmanuel ; Souza, Robson Francisco de ; Mayer, Marcia Pinto Alves
Source: Microorganisms ISSN:2076-2607. Unidades: ICB, FO
Subjects: MICROBIOLOGIA, PERIODONTITE, LACTOBACILLUS, PROBIÓTICOS, PORPHYROMONAS GINGIVALIS, INFECÇÕES BACTERIANAS GRAM-NEGATIVAS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CATARUCI, Amália Cristina de Souza et al. Oral administration of Lactobacillus acidophilus LA5 prevents alveolar bone loss and alters oral and gut microbiomes in a murine periodontitis experimental model. Microorganisms ISSN:2076-2607, v. 12, n. 6, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3390/microorganisms12061057. Acesso em: 16 nov. 2024.
APA
Cataruci, A. C. de S., Kawamoto, D., Shimabukuro, N., Ishikawa, K. H., Ando-Suguimoto, E. S., Ribeiro, R. A., et al. (2024). Oral administration of Lactobacillus acidophilus LA5 prevents alveolar bone loss and alters oral and gut microbiomes in a murine periodontitis experimental model. Microorganisms ISSN:2076-2607, 12( 6), 14 . doi:10.3390/microorganisms12061057
NLM
Cataruci AC de S, Kawamoto D, Shimabukuro N, Ishikawa KH, Ando-Suguimoto ES, Ribeiro RA, Nicastro GG, Albuquerque-Souza E, Souza RF de, Mayer MPA. Oral administration of Lactobacillus acidophilus LA5 prevents alveolar bone loss and alters oral and gut microbiomes in a murine periodontitis experimental model [Internet]. Microorganisms ISSN:2076-2607. 2024 ; 12( 6): 14 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/microorganisms12061057
Vancouver
Cataruci AC de S, Kawamoto D, Shimabukuro N, Ishikawa KH, Ando-Suguimoto ES, Ribeiro RA, Nicastro GG, Albuquerque-Souza E, Souza RF de, Mayer MPA. Oral administration of Lactobacillus acidophilus LA5 prevents alveolar bone loss and alters oral and gut microbiomes in a murine periodontitis experimental model [Internet]. Microorganisms ISSN:2076-2607. 2024 ; 12( 6): 14 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/microorganisms12061057
Artigo de periodico
Lactobacillus acidophilus LA-5 ameliorates inflammation and alveolar bone loss promoted by A. Actinomycetemcomitans and S. gordonii in mice and impacts oral and gut microbiomes (2024)
Bueno, Manuela Rocha ; Martins, Fernando Henrique ; Rocha, Catarina Medeiros ; Kawamoto, Dione ; Ishikawa, Karin Hitomi ; Ando-Suguimoto, Ellen Sayuri; Carlucci, Aline Ramos ; Arroteia, Leticia S.; Casarin, Renato V. ; Mayer, Marcia Pinto Alves
Source: Microorganisms. Unidades: ICB, FO
Subjects: MICROBIOLOGIA, GENÉTICA ODONTOLÓGICA, LACTOBACILLUS, ACTINOBACILLUS ACTINOMYCETEMCOMITANS, BACTÉRIAS GRAM-NEGATIVAS, INFECÇÕES BACTERIANAS GRAM-NEGATIVAS, INFLAMAÇÃO, CAVIDADE DENTÁRIA, OSSO E OSSOS, PERIODONTITE, PROBIÓTICOS, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, Manuela Rocha et al. Lactobacillus acidophilus LA-5 ameliorates inflammation and alveolar bone loss promoted by A. Actinomycetemcomitans and S. gordonii in mice and impacts oral and gut microbiomes. Microorganisms, v. 12, n. 4, p. 14 , 2024Tradução . . Disponível em: https://doi.org/10.3390/microorganisms12040836. Acesso em: 16 nov. 2024.
APA
Bueno, M. R., Martins, F. H., Rocha, C. M., Kawamoto, D., Ishikawa, K. H., Ando-Suguimoto, E. S., et al. (2024). Lactobacillus acidophilus LA-5 ameliorates inflammation and alveolar bone loss promoted by A. Actinomycetemcomitans and S. gordonii in mice and impacts oral and gut microbiomes. Microorganisms, 12( 4), 14 . doi:10.3390/microorganisms12040836
NLM
Bueno MR, Martins FH, Rocha CM, Kawamoto D, Ishikawa KH, Ando-Suguimoto ES, Carlucci AR, Arroteia LS, Casarin RV, Mayer MPA. Lactobacillus acidophilus LA-5 ameliorates inflammation and alveolar bone loss promoted by A. Actinomycetemcomitans and S. gordonii in mice and impacts oral and gut microbiomes [Internet]. Microorganisms. 2024 ; 12( 4): 14 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/microorganisms12040836
Vancouver
Bueno MR, Martins FH, Rocha CM, Kawamoto D, Ishikawa KH, Ando-Suguimoto ES, Carlucci AR, Arroteia LS, Casarin RV, Mayer MPA. Lactobacillus acidophilus LA-5 ameliorates inflammation and alveolar bone loss promoted by A. Actinomycetemcomitans and S. gordonii in mice and impacts oral and gut microbiomes [Internet]. Microorganisms. 2024 ; 12( 4): 14 .[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/microorganisms12040836
Artigo de periodico
Saps1-3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice (2024)
Barbosa, Pedro F.; Gonçalves, Diego de Souza ; Ramos, Lívia de Souza ; Mello, Thais P. ; Braga-Silva, Lys A.; Pinto, Marcia R.; Branquinha, Marta H. ; Santos, André L. S. ; Taborda, Carlos Pelleschi
Source: Infectious Disease Reports. Unidade: IMT
Subjects: MICROBIOLOGIA, INIBIDORES DE ENZIMAS, ANTÍGENOS DE FUNGOS, FUNGOS MITOSPORICOS, CAMUNDONGOS, ALBUMINAS, CÉLULAS EPITELIAIS, MACRÓFAGOS, LEVEDURAS, CANDIDA ALBICANS, INFECÇÕES BACTERIANAS E MICOSES, CITOMETRIA DE FLUXO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Pedro F. et al. Saps1-3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice. Infectious Disease Reports, v. 16, n. 4, p. 572-586, 2024Tradução . . Disponível em: https://doi.org/10.3390/idr16040043. Acesso em: 16 nov. 2024.
APA
Barbosa, P. F., Gonçalves, D. de S., Ramos, L. de S., Mello, T. P., Braga-Silva, L. A., Pinto, M. R., et al. (2024). Saps1-3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice. Infectious Disease Reports, 16( 4), 572-586. doi:10.3390/idr16040043
NLM
Barbosa PF, Gonçalves D de S, Ramos L de S, Mello TP, Braga-Silva LA, Pinto MR, Branquinha MH, Santos ALS, Taborda CP. Saps1-3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice [Internet]. Infectious Disease Reports. 2024 ; 16( 4): 572-586.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/idr16040043
Vancouver
Barbosa PF, Gonçalves D de S, Ramos L de S, Mello TP, Braga-Silva LA, Pinto MR, Branquinha MH, Santos ALS, Taborda CP. Saps1-3 antigens in Candida albicans: differential modulation following exposure to soluble proteins, mammalian cells, and infection in mice [Internet]. Infectious Disease Reports. 2024 ; 16( 4): 572-586.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/idr16040043
Artigo de periodico
Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern (2023)
Azevedo, Patrick Orestes de ; Souza, Natália Satchiko Hojo ; Faustino, Lídia Paula ; Fumagalli, Marcílio Jorge ; Hirako, Isabella C. ; Oliveira, Emiliano R.; Figueiredo, Maria M. ; Carvalho, Alex F.; Doro, Daniel; Benevides, Luciana ; Fonseca, Flávio; Machado, Alexandre M.; Fernandes, Ana P.; Teixeira, Santuza R. ; Silva, João S.; Gazzinelli, Ricardo T, ; Durigon, Edison Luiz
Source: npj Vaccines. Unidade: ICB
Subjects: MICROBIOLOGIA, COVID-19, REPLICAÇÃO VIRAL, VARIAÇÃO GENÉTICA, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS, HAMSTERS, EPITOPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AZEVEDO, Patrick Orestes de et al. Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern. npj Vaccines, v. 8, p. 1-17, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41541-023-00616-y. Acesso em: 16 nov. 2024.
APA
Azevedo, P. O. de, Souza, N. S. H., Faustino, L. P., Fumagalli, M. J., Hirako, I. C., Oliveira, E. R., et al. (2023). Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern. npj Vaccines, 8, 1-17. doi:10.1038/s41541-023-00616-y
NLM
Azevedo PO de, Souza NSH, Faustino LP, Fumagalli MJ, Hirako IC, Oliveira ER, Figueiredo MM, Carvalho AF, Doro D, Benevides L, Fonseca F, Machado AM, Fernandes AP, Teixeira SR, Silva JS, Gazzinelli RT, Durigon EL. Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern [Internet]. npj Vaccines. 2023 ; 8 1-17.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41541-023-00616-y
Vancouver
Azevedo PO de, Souza NSH, Faustino LP, Fumagalli MJ, Hirako IC, Oliveira ER, Figueiredo MM, Carvalho AF, Doro D, Benevides L, Fonseca F, Machado AM, Fernandes AP, Teixeira SR, Silva JS, Gazzinelli RT, Durigon EL. Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern [Internet]. npj Vaccines. 2023 ; 8 1-17.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1038/s41541-023-00616-y
Artigo de periodico
The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo (2023)
Amarante, Maria Fernanda de Castro ; Pereira, Samuel Santos ; Pereira, Lennon Ramos ; Santos, Lucas Souza ; Carvalho, Alexia Adrianne Venceslau ; Martins, Eduardo Gimenes; Balan, Andrea ; Ferreira, Luís Carlos de Souza
Source: Viruses. Unidade: ICB
Subjects: MICROBIOLOGIA, PEPTÍDEOS, ZIKA VÍRUS, DENGUE ANIMAL, ANTIVIRAIS, FLAVIVIRUS, VÍRUS DA DENGUE, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS, INFECÇÕES POR VÍRUS DE RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARANTE, Maria Fernanda de Castro et al. The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo. Viruses, v. 15, n. 4, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15040839. Acesso em: 16 nov. 2024.
APA
Amarante, M. F. de C., Pereira, S. S., Pereira, L. R., Santos, L. S., Carvalho, A. A. V., Martins, E. G., et al. (2023). The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo. Viruses, 15( 4), 1-11. doi:10.3390/v15040839
NLM
Amarante MF de C, Pereira SS, Pereira LR, Santos LS, Carvalho AAV, Martins EG, Balan A, Ferreira LC de S. The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo [Internet]. Viruses. 2023 ; 15( 4): 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/v15040839
Vancouver
Amarante MF de C, Pereira SS, Pereira LR, Santos LS, Carvalho AAV, Martins EG, Balan A, Ferreira LC de S. The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo [Internet]. Viruses. 2023 ; 15( 4): 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/v15040839
Artigo de periodico
Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice (2023)
Santos, Yasmin da Silva ; Oliveira, Danielle Bruna Leal de ; Palmisano, Giuseppe ; Wrenger, Carsten ; Covas, Dimas Tadeu ; Curi, Rui ; Marinho, Claudio Romero Farias ; Durigon, Edison Luiz ; Epiphanio, Sabrina
Source: Viruses. Unidades: ICB, FMRP, FCF
Subjects: MICROBIOLOGIA, PARASITOLOGIA, COVID-19, VARIAÇÃO GENÉTICA, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, VIRULÊNCIA, CORONAVIRUS, INFECÇÕES POR CORONAVIRUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Yasmin da Silva et al. Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice. Viruses, v. 15, n. 4, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15040999. Acesso em: 16 nov. 2024.
APA
Santos, Y. da S., Oliveira, D. B. L. de, Palmisano, G., Wrenger, C., Covas, D. T., Curi, R., et al. (2023). Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice. Viruses, 15( 4), 1-16. doi:10.3390/v15040999
NLM
Santos Y da S, Oliveira DBL de, Palmisano G, Wrenger C, Covas DT, Curi R, Marinho CRF, Durigon EL, Epiphanio S. Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice [Internet]. Viruses. 2023 ; 15( 4): 1-16.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/v15040999
Vancouver
Santos Y da S, Oliveira DBL de, Palmisano G, Wrenger C, Covas DT, Curi R, Marinho CRF, Durigon EL, Epiphanio S. Virulence profiles of Wild-Type, P.1 and Delta SARS-CoV-2 variants in K18-hACE2 transgenic mice [Internet]. Viruses. 2023 ; 15( 4): 1-16.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/v15040999
Artigo de periodico
Targeting the P10 peptide in maturing dendritic cells via the DEC205 receptor in vivo: a new therapeutic strategy against Paracoccidioidomycosis (2023)
Santos, Suelen S. ; Rampazo, Eline; Nosanchuk, Joshua D. ; Boscardin, Silvia B. ; Almeida, Sandro Rogério de ; Taborda, Carlos Pelleschi
Source: Journal of Fungi. Unidades: ICB, FCF
Subjects: MICROBIOLOGIA, PARASITOLOGIA, PARACOCCIDIOIDOMICOSE, PARACOCCIDIOIDES BRASILIENSIS, CÉLULAS DENDRÍTICAS, PEPTÍDEOS, ANTICORPOS MONOCLONAIS, VACINAS, LINFÓCITOS T, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Suelen S. et al. Targeting the P10 peptide in maturing dendritic cells via the DEC205 receptor in vivo: a new therapeutic strategy against Paracoccidioidomycosis. Journal of Fungi, v. 9, n. 5, p. 1-12, 2023Tradução . . Disponível em: https://doi.org/10.3390/jof9050548. Acesso em: 16 nov. 2024.
APA
Santos, S. S., Rampazo, E., Nosanchuk, J. D., Boscardin, S. B., Almeida, S. R. de, & Taborda, C. P. (2023). Targeting the P10 peptide in maturing dendritic cells via the DEC205 receptor in vivo: a new therapeutic strategy against Paracoccidioidomycosis. Journal of Fungi, 9( 5), 1-12. doi:10.3390/jof9050548
NLM
Santos SS, Rampazo E, Nosanchuk JD, Boscardin SB, Almeida SR de, Taborda CP. Targeting the P10 peptide in maturing dendritic cells via the DEC205 receptor in vivo: a new therapeutic strategy against Paracoccidioidomycosis [Internet]. Journal of Fungi. 2023 ; 9( 5): 1-12.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/jof9050548
Vancouver
Santos SS, Rampazo E, Nosanchuk JD, Boscardin SB, Almeida SR de, Taborda CP. Targeting the P10 peptide in maturing dendritic cells via the DEC205 receptor in vivo: a new therapeutic strategy against Paracoccidioidomycosis [Internet]. Journal of Fungi. 2023 ; 9( 5): 1-12.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/jof9050548
Artigo de periodico
Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine (2023)
Sayedahmed, Ekramy E. ; Araujo, Marcelo Valdemir de ; Silva-Pereira, Taiana Tainá ; Shubhada K. Chothe ; Elkashif, Ahmed; Alhashimi, Marwa ; Wang, Wen-Chien; Santos, Andrea P.; Nair, Meera Surendran ; Gontu, Abhinay ; Nissly, Ruth ; Souza Filho, Antonio Francisco de ; Tavares, Mariana Silva; Ayupe, Marina Caçador ; Salgado, Caio Loureiro ; Candido, Érika Donizetti ; Oliveira, Danielle Bruna Leal de ; Jagannath, Chinnaswamy ; Kuchipudi, Suresh V. ; Mittal, Suresh K. ; Heinemann, Marcos Bryan ; Durigon, Edison Luiz ; Fonseca, Denise Morais da ; Guimarães, Ana Marcia de Sá
Source: Molecular Therapy - Methods & Clinical Development. Unidades: FMVZ, ICB, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, IMUNOLOGIA, PEPTÍDEOS, ADENOVÍRUS, VÍRUS DE DNA, VACINAS VIRAIS, IMUNOGENICIDADE DA VACINA, HAMSTERS, VARIAÇÃO (BIOLOGIA), CORONAVIRUS, DOENÇAS RESPIRATÓRIAS, CAMUNDONGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SAYEDAHMED, Ekramy E. et al. Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine. Molecular Therapy - Methods & Clinical Development, v. 30, p. 194-207, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.omtm.2023.06.009. Acesso em: 16 nov. 2024.
APA
Sayedahmed, E. E., Araujo, M. V. de, Silva-Pereira, T. T., Shubhada K. Chothe,, Elkashif, A., Alhashimi, M., et al. (2023). Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine. Molecular Therapy - Methods & Clinical Development, 30, 194-207. doi:10.1016/j.omtm.2023.06.009
NLM
Sayedahmed EE, Araujo MV de, Silva-Pereira TT, Shubhada K. Chothe, Elkashif A, Alhashimi M, Wang W-C, Santos AP, Nair MS, Gontu A, Nissly R, Souza Filho AF de, Tavares MS, Ayupe MC, Salgado CL, Candido ÉD, Oliveira DBL de, Jagannath C, Kuchipudi SV, Mittal SK, Heinemann MB, Durigon EL, Fonseca DM da, Guimarães AM de S. Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine [Internet]. Molecular Therapy - Methods & Clinical Development. 2023 ; 30 194-207.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.omtm.2023.06.009
Vancouver
Sayedahmed EE, Araujo MV de, Silva-Pereira TT, Shubhada K. Chothe, Elkashif A, Alhashimi M, Wang W-C, Santos AP, Nair MS, Gontu A, Nissly R, Souza Filho AF de, Tavares MS, Ayupe MC, Salgado CL, Candido ÉD, Oliveira DBL de, Jagannath C, Kuchipudi SV, Mittal SK, Heinemann MB, Durigon EL, Fonseca DM da, Guimarães AM de S. Impact of an autophagy-inducing peptide on immunogenicity and protection efficacy of an adenovirus-vectored SARS-CoV-2 vaccine [Internet]. Molecular Therapy - Methods & Clinical Development. 2023 ; 30 194-207.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.omtm.2023.06.009
Artigo de periodico
Biodistribution and adjuvant effect of an intranasal vaccine based on Chitosan Nanoparticles against Paracoccidioidomycosis (2023)
Santos Júnior, Samuel Rodrigues dos ; Barbalho, Filipe Vieira ; Nosanchuk, Joshua D. ; Amaral, Andre Correa ; Taborda, Carlos Pelleschi
Source: Journal of Fungi. Unidade: ICB
Subjects: MICROBIOLOGIA, PARACOCCIDIOIDES, PARACOCCIDIOIDOMICOSE, NANOPARTÍCULAS, ADJUVANTES IMUNOLÓGICOS, VACINAS, QUITOSANA, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS JÚNIOR, Samuel Rodrigues dos et al. Biodistribution and adjuvant effect of an intranasal vaccine based on Chitosan Nanoparticles against Paracoccidioidomycosis. Journal of Fungi, v. 9, n. 2, p. 1-18, 2023Tradução . . Disponível em: https://doi.org/10.3390/jof9020245. Acesso em: 16 nov. 2024.
APA
Santos Júnior, S. R. dos, Barbalho, F. V., Nosanchuk, J. D., Amaral, A. C., & Taborda, C. P. (2023). Biodistribution and adjuvant effect of an intranasal vaccine based on Chitosan Nanoparticles against Paracoccidioidomycosis. Journal of Fungi, 9( 2), 1-18. doi:10.3390/jof9020245
NLM
Santos Júnior SR dos, Barbalho FV, Nosanchuk JD, Amaral AC, Taborda CP. Biodistribution and adjuvant effect of an intranasal vaccine based on Chitosan Nanoparticles against Paracoccidioidomycosis [Internet]. Journal of Fungi. 2023 ; 9( 2): 1-18.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/jof9020245
Vancouver
Santos Júnior SR dos, Barbalho FV, Nosanchuk JD, Amaral AC, Taborda CP. Biodistribution and adjuvant effect of an intranasal vaccine based on Chitosan Nanoparticles against Paracoccidioidomycosis [Internet]. Journal of Fungi. 2023 ; 9( 2): 1-18.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3390/jof9020245
Artigo de periodico
Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice (2023)
Machado, R. Rahal Guaragna ; Rafael, G. H.; Scharton, D.; Campos, R. Kroon; Liang, Y.; Plante, K. S.; Weaver, S. C.; Durigon, E. L.
Source: International Journal of Infectious Diseases. Conference titles: International Congress on Infectious Diseases. Unidade: ICB
Subjects: MICROBIOLOGIA, DOENÇAS INFECCIOSAS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, INTERFERONS, ANTICORPOS, FENÓTIPOS, CITOCINAS, LINHAGENS ANIMAIS, INFLAMAÇÃO, QUIMIOCINAS, VIROSES EM ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, R. Rahal Guaragna et al. Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice. International Journal of Infectious Diseases, v. 130, p. S18, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijid.2023.04.044. Acesso em: 16 nov. 2024.
APA
Machado, R. R. G., Rafael, G. H., Scharton, D., Campos, R. K., Liang, Y., Plante, K. S., et al. (2023). Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice. International Journal of Infectious Diseases, 130, S18. doi:10.1016/j.ijid.2023.04.044
NLM
Machado RRG, Rafael GH, Scharton D, Campos RK, Liang Y, Plante KS, Weaver SC, Durigon EL. Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice [Internet]. International Journal of Infectious Diseases. 2023 ; 130 S18.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ijid.2023.04.044
Vancouver
Machado RRG, Rafael GH, Scharton D, Campos RK, Liang Y, Plante KS, Weaver SC, Durigon EL. Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice [Internet]. International Journal of Infectious Diseases. 2023 ; 130 S18.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.ijid.2023.04.044
Artigo de periodico
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice (2023)
Silva, Jamile Ramos da ; Rodrigues, Karine Bitencourt ; Pelegrin, Guilherme Formoso ; Sales, Natiely Silva ; Muramatsu, Hiromi ; Silva, Mariângela de Oliveira ; Porchia, Bruna Felício Milazzotto Maldonado ; Moreno, Ana Carolina Ramos ; Aps, Luana Raposo M. M. ; Carvalho, Aléxia Adrianne Venceslau ; Tombácz, István ; Fotoran, Wesley Luzetti ; Karikó, Katalin ; Lin, Paulo J. C.; Tam, Ying K. ; Diniz, Mariana de Oliveira ; Pardi, Norbert ; Ferreira, Luís Carlos de Souza
Source: Science Translational Medicine. Unidades: ICB, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, VACINAS VIRAIS, MODELOS ANIMAIS DE DOENÇAS, CAMUNDONGOS, PAPILLOMAVIRUS, HPV, INFECÇÕES POR PAPILLOMAVIRUS, NEOPLASIAS DO COLO UTERINO, PROTEÍNAS RECOMBINANTES, NANOPARTÍCULAS, NUCLEOSÍDEOS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jamile Ramos da et al. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice. Science Translational Medicine, v. 15, n. 686, p. 1-18, 2023Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.abn3464. Acesso em: 16 nov. 2024.
APA
Silva, J. R. da, Rodrigues, K. B., Pelegrin, G. F., Sales, N. S., Muramatsu, H., Silva, M. de O., et al. (2023). Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice. Science Translational Medicine, 15( 686), 1-18. doi:10.1126/scitranslmed.abn3464
NLM
Silva JR da, Rodrigues KB, Pelegrin GF, Sales NS, Muramatsu H, Silva M de O, Porchia BFMM, Moreno ACR, Aps LRMM, Carvalho AAV, Tombácz I, Fotoran WL, Karikó K, Lin PJC, Tam YK, Diniz M de O, Pardi N, Ferreira LC de S. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice [Internet]. Science Translational Medicine. 2023 ; 15( 686): 1-18.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1126/scitranslmed.abn3464
Vancouver
Silva JR da, Rodrigues KB, Pelegrin GF, Sales NS, Muramatsu H, Silva M de O, Porchia BFMM, Moreno ACR, Aps LRMM, Carvalho AAV, Tombácz I, Fotoran WL, Karikó K, Lin PJC, Tam YK, Diniz M de O, Pardi N, Ferreira LC de S. Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice [Internet]. Science Translational Medicine. 2023 ; 15( 686): 1-18.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1126/scitranslmed.abn3464
Artigo de periodico
SARS-CoV-2 nanovaccine composed of microfluidic-produced gold nanoparticles induces neutralizing immune responses (2023)
Dalibera, Natália Cristina ; Rodrigues-Jesus, Monica Josiane ; Andreata-Santos, Robert ; Janini, Luiz Mário Ramos ; Oliveira, Aline Furtado ; Azzoni, Adriano Rodrigues ; Ferreira, Luis Carlos de Souza
Source: ACS Applied Nano Materials. Unidades: EP, ICB
Subjects: MICROBIOLOGIA, NANOPARTÍCULAS, VACINAS VIRAIS, COVID-19, PEPTÍDEOS, PROTEÍNAS, CORONAVIRUS, DOENÇAS RESPIRATÓRIAS, SISTEMA IMUNE, IMUNOGLOBULINAS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DALIBERA, Natália Cristina et al. SARS-CoV-2 nanovaccine composed of microfluidic-produced gold nanoparticles induces neutralizing immune responses. ACS Applied Nano Materials, v. 6, n. 24, p. 22774-22783, 2023Tradução . . Disponível em: https://doi.org/10.1021/acsanm.3c03905. Acesso em: 16 nov. 2024.
APA
Dalibera, N. C., Rodrigues-Jesus, M. J., Andreata-Santos, R., Janini, L. M. R., Oliveira, A. F., Azzoni, A. R., & Ferreira, L. C. de S. (2023). SARS-CoV-2 nanovaccine composed of microfluidic-produced gold nanoparticles induces neutralizing immune responses. ACS Applied Nano Materials, 6( 24), 22774-22783. doi:10.1021/acsanm.3c03905
NLM
Dalibera NC, Rodrigues-Jesus MJ, Andreata-Santos R, Janini LMR, Oliveira AF, Azzoni AR, Ferreira LC de S. SARS-CoV-2 nanovaccine composed of microfluidic-produced gold nanoparticles induces neutralizing immune responses [Internet]. ACS Applied Nano Materials. 2023 ; 6( 24): 22774-22783.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1021/acsanm.3c03905
Vancouver
Dalibera NC, Rodrigues-Jesus MJ, Andreata-Santos R, Janini LMR, Oliveira AF, Azzoni AR, Ferreira LC de S. SARS-CoV-2 nanovaccine composed of microfluidic-produced gold nanoparticles induces neutralizing immune responses [Internet]. ACS Applied Nano Materials. 2023 ; 6( 24): 22774-22783.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1021/acsanm.3c03905
Artigo de periodico
Photorepair of either CPD or 6-4PP DNA lesions in basal Keratinocytes attenuates ultraviolet-induced skin effects in nucleotide excision repair deficient mice (2022)
Kajitani, Gustavo Satoru; Quayle, Carolina de Barros Reis ; Garcia, Camila Carrião Machado ; Fotoran, Wesley Luzetti ; Santos, Juliana F. R. dos; Horst, Gijsbertus T. J. van der ; Hoeijmakers, Jan H. J. ; Menck, Carlos Frederico Martins
Source: Frontiers in Immunology. Unidades: ICB, IB, BIOTECNOLOGIA
Subjects: MICROBIOLOGIA, RADIAÇÃO ULTRAVIOLETA, REPARAÇÃO DE DNA, CÉLULAS MORTAS, NEOPLASIAS CUTÂNEAS, CAMUNDONGOS, MODELOS ANIMAIS DE DOENÇAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAJITANI, Gustavo Satoru et al. Photorepair of either CPD or 6-4PP DNA lesions in basal Keratinocytes attenuates ultraviolet-induced skin effects in nucleotide excision repair deficient mice. Frontiers in Immunology, v. 13, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2022.800606. Acesso em: 16 nov. 2024.
APA
Kajitani, G. S., Quayle, C. de B. R., Garcia, C. C. M., Fotoran, W. L., Santos, J. F. R. dos, Horst, G. T. J. van der, et al. (2022). Photorepair of either CPD or 6-4PP DNA lesions in basal Keratinocytes attenuates ultraviolet-induced skin effects in nucleotide excision repair deficient mice. Frontiers in Immunology, 13, 1-10. doi:10.3389/fimmu.2022.800606
NLM
Kajitani GS, Quayle C de BR, Garcia CCM, Fotoran WL, Santos JFR dos, Horst GTJ van der, Hoeijmakers JHJ, Menck CFM. Photorepair of either CPD or 6-4PP DNA lesions in basal Keratinocytes attenuates ultraviolet-induced skin effects in nucleotide excision repair deficient mice [Internet]. Frontiers in Immunology. 2022 ; 13 1-10.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fimmu.2022.800606
Vancouver
Kajitani GS, Quayle C de BR, Garcia CCM, Fotoran WL, Santos JFR dos, Horst GTJ van der, Hoeijmakers JHJ, Menck CFM. Photorepair of either CPD or 6-4PP DNA lesions in basal Keratinocytes attenuates ultraviolet-induced skin effects in nucleotide excision repair deficient mice [Internet]. Frontiers in Immunology. 2022 ; 13 1-10.[citado 2024 nov. 16 ] Available from: https://doi.org/10.3389/fimmu.2022.800606
Artigo de periodico
Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation (2022)
Jesus, Monica Josiane Rodrigues de ; Favaro, Marianna Teixeira de Pinho ; Carvalho, Aléxia Adrianne Venceslau Brito ; Amarante, Maria Fernanda de Castro ; Almeida, Bianca da Silva ; Silva, Mariângela de Oliveira ; Santos, Robert Andreata ; Barbosa, Cecilia Gomes; Brito, Samantha Carvalho Maia; Freitas Junior, Lucio Holanda Gondim de ; Boscardin, Silvia Beatriz ; Ferreira, Luís Carlos de Souza
Source: Nanomedicine: Nanotechnology, Biology and Medicine. Unidades: BIOTECNOLOGIA, ICB
Subjects: PARASITOLOGIA, MICROBIOLOGIA, VACINAS VIRAIS, IMUNOGLOBULINAS, CORONAVIRUS, COVID-19, LIPOPROTEÍNAS, NANOPARTÍCULAS, CAMUNDONGOS, IMUNOGENICIDADE DA VACINA, DOENÇAS RESPIRATÓRIAS, GLICOPROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JESUS, Monica Josiane Rodrigues de et al. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation. Nanomedicine: Nanotechnology, Biology and Medicine, v. 45, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.nano.2022.102595. Acesso em: 16 nov. 2024.
APA
Jesus, M. J. R. de, Favaro, M. T. de P., Carvalho, A. A. V. B., Amarante, M. F. de C., Almeida, B. da S., Silva, M. de O., et al. (2022). Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation. Nanomedicine: Nanotechnology, Biology and Medicine, 45, 1-11. doi:10.1016/j.nano.2022.102595
NLM
Jesus MJR de, Favaro MT de P, Carvalho AAVB, Amarante MF de C, Almeida B da S, Silva M de O, Santos RA, Barbosa CG, Brito SCM, Freitas Junior LHG de, Boscardin SB, Ferreira LC de S. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2022 ; 45 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.nano.2022.102595
Vancouver
Jesus MJR de, Favaro MT de P, Carvalho AAVB, Amarante MF de C, Almeida B da S, Silva M de O, Santos RA, Barbosa CG, Brito SCM, Freitas Junior LHG de, Boscardin SB, Ferreira LC de S. Nano-multilamellar lipid vesicles promote the induction of SARS-CoV-2 immune responses by a protein-based vaccine formulation [Internet]. Nanomedicine: Nanotechnology, Biology and Medicine. 2022 ; 45 1-11.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.nano.2022.102595
Artigo de periodico
Streptococcus mutans glutamate binding protein (GlnH) as antigen target for a mucosal anti-caries vaccine (2022)
Pereira, Gisela de Souza; Batista, Milene Tavares ; Santos, Nayara Fernanda Barros dos ; Passos, Hélic Moreira; Silva, Dalva Adelina da; Ferreira, Ewerton Lucena ; Ferreira, Luís Carlos de Souza ; Ferreira, Rita de Cássia Café
Source: Brazilian Journal of Microbiology. Unidade: ICB
Subjects: MICROBIOLOGIA, CAMUNDONGOS, INFECÇÕES BACTERIANAS GRAM-POSITIVAS, GLUTAMATOS, CÁRIE DENTÁRIA, STREPTOCOCCUS MUTANS, VACINAS, MUCOSA ORAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Gisela de Souza et al. Streptococcus mutans glutamate binding protein (GlnH) as antigen target for a mucosal anti-caries vaccine. Brazilian Journal of Microbiology, p. 1-9, 2022Tradução . . Disponível em: https://doi.org/10.1007/s42770-022-00823-0. Acesso em: 16 nov. 2024.
APA
Pereira, G. de S., Batista, M. T., Santos, N. F. B. dos, Passos, H. M., Silva, D. A. da, Ferreira, E. L., et al. (2022). Streptococcus mutans glutamate binding protein (GlnH) as antigen target for a mucosal anti-caries vaccine. Brazilian Journal of Microbiology, 1-9. doi:10.1007/s42770-022-00823-0
NLM
Pereira G de S, Batista MT, Santos NFB dos, Passos HM, Silva DA da, Ferreira EL, Ferreira LC de S, Ferreira R de CC. Streptococcus mutans glutamate binding protein (GlnH) as antigen target for a mucosal anti-caries vaccine [Internet]. Brazilian Journal of Microbiology. 2022 ; 1-9.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s42770-022-00823-0
Vancouver
Pereira G de S, Batista MT, Santos NFB dos, Passos HM, Silva DA da, Ferreira EL, Ferreira LC de S, Ferreira R de CC. Streptococcus mutans glutamate binding protein (GlnH) as antigen target for a mucosal anti-caries vaccine [Internet]. Brazilian Journal of Microbiology. 2022 ; 1-9.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s42770-022-00823-0
Artigo de periodico
Chronic exposure to cigarette smoke transiently worsens the disease course in a mouse model of pulmonary paracoccidioidomycosis (2022)
Oliveira, Renata Buccheri de ; Duarte Neto, Amaro Nunes ; Silva, Flaviano Luiz Batista; Haddad, Gabrielle Carvalho; Silva, Leandro Buffoni Roque da ; Azevedo Netto, Raymundo; Ledesma, Felipe Lourenço ; Taborda, Carlos Pelleschi ; Benard, Gil
Source: Revista do Instituto de Medicina Tropical de São Paulo. Unidades: FM, ICB
Subjects: MICROBIOLOGIA, PARACOCCIDIOIDOMICOSE, INFECÇÕES BACTERIANAS E MICOSES, MODELOS ANIMAIS DE DOENÇAS, INTERLEUCINA 10, GRANULOMA, TABAGISMO, FUMANTES, CAMUNDONGOS, IMUNOHISTOQUÍMICA, LINFÓCITOS, MACRÓFAGOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Renata Buccheri de et al. Chronic exposure to cigarette smoke transiently worsens the disease course in a mouse model of pulmonary paracoccidioidomycosis. Revista do Instituto de Medicina Tropical de São Paulo, v. 64, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1590/S1678-9946202264071. Acesso em: 16 nov. 2024.
APA
Oliveira, R. B. de, Duarte Neto, A. N., Silva, F. L. B., Haddad, G. C., Silva, L. B. R. da, Azevedo Netto, R., et al. (2022). Chronic exposure to cigarette smoke transiently worsens the disease course in a mouse model of pulmonary paracoccidioidomycosis. Revista do Instituto de Medicina Tropical de São Paulo, 64, 1-10. doi:10.1590/S1678-9946202264071
NLM
Oliveira RB de, Duarte Neto AN, Silva FLB, Haddad GC, Silva LBR da, Azevedo Netto R, Ledesma FL, Taborda CP, Benard G. Chronic exposure to cigarette smoke transiently worsens the disease course in a mouse model of pulmonary paracoccidioidomycosis [Internet]. Revista do Instituto de Medicina Tropical de São Paulo. 2022 ; 64 1-10.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1590/S1678-9946202264071
Vancouver
Oliveira RB de, Duarte Neto AN, Silva FLB, Haddad GC, Silva LBR da, Azevedo Netto R, Ledesma FL, Taborda CP, Benard G. Chronic exposure to cigarette smoke transiently worsens the disease course in a mouse model of pulmonary paracoccidioidomycosis [Internet]. Revista do Instituto de Medicina Tropical de São Paulo. 2022 ; 64 1-10.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1590/S1678-9946202264071

USP Schools

ReP

Filtros

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration